Literature DB >> 18273909

Liver prenylated methylated protein methyl esterase is the same enzyme as Sus scrofa carboxylesterase.

Onovughode T Oboh1, Nazarius S Lamango.   

Abstract

The C-terminal --COOH of prenylated proteins is methylated to --COOCH3. The --COOCH3 ester forms are hydrolyzed by prenylated methylated protein methyl esterase (PMPMEase) to the original acid forms. This is the only reversible step of the prenylation pathway. PMPMEase has not been purified and identified and is therefore understudied. Using a prenylated-L-cysteine methyl ester as substrate, PMPMEase was purified to apparent homogeneity from porcine liver supernatant. SDS-PAGE analysis revealed an apparent mass of 57 kDa. Proteomics analyses identified 17 peptides (242 amino acids). A Mascot database search revealed these as portions of the Sus scrofa carboxylesterase, a 62-kDa serine hydrolase with the C-terminal HAEL endoplasmic reticulum-retention signal. It is at least 71% identical to such mammalian carboxylesterases as human carboxylesterase 1 with affinities toward hydrophobic substrates and known to activate prodrugs, metabolize active drugs, as well as detoxify various substances such as cocaine and food-derived esters. The purified enzyme hydrolyzed benzoyl-Gly-farnesyl-L-cysteine methyl ester and hydrocinamoyl farnesyl-L-cysteine methyl ester with Michaelis-Menten constant (K(m)) values of 33 +/- 4 and 25 +/- 4 microM and V(max) values of 4.51 +/- 0.28 and 6.80 +/- 0.51 nmol/min/mg of protein, respectively. It was inhibited by organophosphates, chloromethyl ketones, ebelactone A and B, and phenylmethylsulfonyl fluoride. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18273909      PMCID: PMC3766356          DOI: 10.1002/jbt.20214

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  52 in total

1.  Quantification of S-adenosylmethionine-induced tremors: a possible tremor model for Parkinson's disease.

Authors:  N S Lamango; R A Nesby; C G Charlton
Journal:  Pharmacol Biochem Behav       Date:  2000-03       Impact factor: 3.533

2.  Pesticide exposure and risk for Parkinson's disease.

Authors:  Alberto Ascherio; Honglei Chen; Marc G Weisskopf; Eilis O'Reilly; Marjorie L McCullough; Eugenia E Calle; Michael A Schwarzschild; Michael J Thun
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

3.  Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.

Authors:  Antony A Cooper; Aaron D Gitler; Anil Cashikar; Cole M Haynes; Kathryn J Hill; Bhupinder Bhullar; Kangning Liu; Kexiang Xu; Katherine E Strathearn; Fang Liu; Songsong Cao; Kim A Caldwell; Guy A Caldwell; Gerald Marsischky; Richard D Kolodner; Joshua Labaer; Jean-Christophe Rochet; Nancy M Bonini; Susan Lindquist
Journal:  Science       Date:  2006-06-22       Impact factor: 47.728

4.  The proprotein convertase SKI-1/S1P. In vitro analysis of Lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors.

Authors:  Antonella Pasquato; Philomena Pullikotil; Marie-Claude Asselin; Manuela Vacatello; Livio Paolillo; Francesca Ghezzo; Federica Basso; Carlo Di Bello; Monica Dettin; Nabil G Seidah
Journal:  J Biol Chem       Date:  2006-06-21       Impact factor: 5.157

5.  A mechanism for organophosphate-induced delayed neuropathy.

Authors:  Paul Glynn
Journal:  Toxicol Lett       Date:  2005-11-23       Impact factor: 4.372

6.  Liver prenylated methylated protein methyl esterase is an organophosphate-sensitive enzyme.

Authors:  Nazarius S Lamango
Journal:  J Biochem Mol Toxicol       Date:  2005       Impact factor: 3.642

Review 7.  Current issues in organophosphate toxicology.

Authors:  Lucio G Costa
Journal:  Clin Chim Acta       Date:  2005-12-06       Impact factor: 3.786

Review 8.  Extrapyramidal parkinsonism complicating acute organophosphate insecticide poisoning.

Authors:  Eli Shahar; Yedidia Bentur; Gad Bar-Joseph; Alfred Cahana; Eli Hershman
Journal:  Pediatr Neurol       Date:  2005-11       Impact factor: 3.372

9.  Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats.

Authors:  N S Lamango; C G Charlton
Journal:  Pharmacol Biochem Behav       Date:  2000-08       Impact factor: 3.533

10.  Rab GTPases containing a CAAX motif are processed post-geranylgeranylation by proteolysis and methylation.

Authors:  Ka Fai Leung; Rudi Baron; Bassam R Ali; Anthony I Magee; Miguel C Seabra
Journal:  J Biol Chem       Date:  2006-11-18       Impact factor: 5.157

View more
  18 in total

1.  Control of RhoA methylation by carboxylesterase I.

Authors:  Ian Cushman; Stephanie M Cushman; Philip M Potter; Patrick J Casey
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

2.  Disruption of actin filaments and suppression of pancreatic cancer cell viability and migration following treatment with polyisoprenylated cysteinyl amides.

Authors:  Augustine T Nkembo; Olufisayo Salako; Rosemary A Poku; Felix Amissah; Elizabeth Ntantie; Hernan Flores-Rozas; Nazarius S Lamango
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

3.  Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.

Authors:  Chi C Wong; Ka-Wing Cheng; Gang Xie; Dingying Zhou; Cai-Hua Zhu; Panayiotis P Constantinides; Basil Rigas
Journal:  J Pharmacol Exp Ther       Date:  2011-11-15       Impact factor: 4.030

4.  Regulation of polyisoprenylated methylated protein methyl esterase by polyunsaturated fatty acids and prostaglandins.

Authors:  Felix Amissah; Shalina Taylor; Randolph Duverna; Lambert T Ayuk-Takem; Nazarius S Lamango
Journal:  Eur J Lipid Sci Technol       Date:  2011-11       Impact factor: 2.679

5.  Polyisoprenylated cysteinyl amide inhibitors induce caspase 3/7- and 8-mediated apoptosis and inhibit migration and invasion of metastatic prostate cancer cells.

Authors:  Rosemary A Poku; Olufisayo O Salako; Felix Amissah; Augustine T Nkembo; Elizabeth Ntantie; Nazarius S Lamango
Journal:  Am J Cancer Res       Date:  2017-07-01       Impact factor: 6.166

6.  Inhibition of polyisoprenylated methylated protein methyl esterase by synthetic musks induces cell degeneration.

Authors:  Lambert Ayuk-Takem; Felix Amissah; Byron J Aguilar; Nazarius S Lamango
Journal:  Environ Toxicol       Date:  2012-04-04       Impact factor: 4.119

7.  Polyisoprenylation potentiates the inhibition of polyisoprenylated methylated protein methyl esterase and the cell degenerative effects of sulfonyl fluorides.

Authors:  Byron Aguilar; Felix Amissah; Randolph Duverna; Nazarius S Lamango
Journal:  Curr Cancer Drug Targets       Date:  2011-07       Impact factor: 3.428

Review 8.  Protein prenylation: unique fats make their mark on biology.

Authors:  Mei Wang; Patrick J Casey
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

Review 9.  Biochemical and docking analysis of substrate interactions with polyisoprenylated methylated protein methyl esterase.

Authors:  R Duverna; S Y Ablordeppey; N S Lamango
Journal:  Curr Cancer Drug Targets       Date:  2010-09       Impact factor: 3.428

10.  Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression.

Authors:  Felix Amissah; Randolph Duverna; Byron J Aguilar; Rosemary A Poku; Gebre-Egziabher Kiros; Nazarius S Lamango
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.